Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Short-term Investments (2016 - 2025)

Medifast (MED) has disclosed Short-term Investments for 15 consecutive years, with $61.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Short-term Investments changed N/A year-over-year to $61.0 million, compared with a TTM value of $61.0 million through Jun 2025, changed N/A, and an annual FY2024 reading of $71.4 million, up 28.44% over the prior year.
  • Short-term Investments was $61.0 million for Q2 2025 at Medifast, down from $72.9 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $72.9 million in Q1 2025 and bottomed at $5.4 million in Q4 2021.
  • Average Short-term Investments over 4 years is $40.2 million, with a median of $54.6 million recorded in 2024.
  • The sharpest move saw Short-term Investments crashed 62.65% in 2021, then rose 28.44% in 2024.
  • Year by year, Short-term Investments stood at $5.4 million in 2021, then skyrocketed by 937.14% to $55.6 million in 2023, then rose by 28.44% to $71.4 million in 2024, then decreased by 14.61% to $61.0 million in 2025.
  • Business Quant data shows Short-term Investments for MED at $61.0 million in Q2 2025, $72.9 million in Q1 2025, and $71.4 million in Q4 2024.